IRIS PubliCatt

Ferraccioli, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.055
EU - Europa 6.787
AS - Asia 2.077
SA - Sud America 42
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 19
Totale 16.040
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.011
DE - Germania 1.787
SE - Svezia 1.054
CN - Cina 1.024
IT - Italia 829
PL - Polonia 734
UA - Ucraina 665
FR - Francia 598
SG - Singapore 389
IE - Irlanda 380
ID - Indonesia 230
GB - Regno Unito 217
FI - Finlandia 182
IN - India 165
RU - Federazione Russa 141
TR - Turchia 94
BE - Belgio 74
HK - Hong Kong 44
JP - Giappone 38
IR - Iran 36
CA - Canada 34
CI - Costa d'Avorio 21
AU - Australia 17
CH - Svizzera 17
NL - Olanda 17
BR - Brasile 13
CL - Cile 13
RO - Romania 13
VN - Vietnam 13
CZ - Repubblica Ceca 12
EU - Europa 12
ES - Italia 11
DK - Danimarca 9
A2 - ???statistics.table.value.countryCode.A2??? 8
ZA - Sudafrica 8
NO - Norvegia 7
CO - Colombia 6
GR - Grecia 6
KR - Corea 6
LK - Sri Lanka 6
MX - Messico 6
SA - Arabia Saudita 6
AR - Argentina 5
BG - Bulgaria 5
IL - Israele 5
AT - Austria 4
EC - Ecuador 4
LV - Lettonia 4
TW - Taiwan 4
BD - Bangladesh 3
EE - Estonia 3
EG - Egitto 3
HU - Ungheria 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
SI - Slovenia 3
A1 - Anonimo 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 16.040
Salva come PNG Salva come JPEG
Città #
Chandler 1.287
Warsaw 602
Ashburn 510
Ann Arbor 390
Jacksonville 388
Dearborn 371
Dublin 363
San Mateo 318
Wilmington 287
Fairfield 273
Singapore 257
Nanjing 249
Woodbridge 238
Jakarta 228
Cattolica 178
Houston 178
Seattle 167
Boston 150
Lawrence 140
New York 131
Kraków 121
Beijing 107
Milan 105
Moscow 103
Redwood City 92
Bremen 91
Marseille 85
Cambridge 83
Izmir 81
Nürnberg 81
Nanchang 76
Munich 71
Princeton 68
Brussels 67
Rome 63
Kunming 60
Norwalk 57
Boardman 55
Lancaster 53
Pune 52
Mountain View 50
Hebei 46
Hong Kong 44
Shenyang 43
Guangzhou 39
Chicago 37
Los Angeles 37
University Park 37
Hangzhou 36
Redmond 35
Tianjin 35
Falls Church 31
Helsinki 31
Hefei 27
Jiaxing 27
Changsha 25
Detroit 23
Fremont 23
Jinan 22
Zhengzhou 22
Abidjan 21
Leawood 21
London 21
Shanghai 21
Andover 20
Augusta 19
Busto Arsizio 15
Toronto 14
Fuzhou 13
San Diego 13
Simi Valley 13
Phoenix 12
Washington 12
Dong Ket 11
Kish 11
Ningbo 11
Tokyo 11
Ardabil 10
Santa Maria 10
Chengdu 9
Costa Mesa 9
Florence 9
Haikou 9
Paris 9
Changchun 8
Clearwater 8
Lanzhou 8
Torino 8
Edinburgh 7
Xian 7
Zurich 7
Bari 6
Dallas 6
Forest City 6
Herenthout 6
Melbourne 6
Monmouth Junction 6
Rozzano 6
Sandston 6
Springfield 6
Totale 9.377
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 378
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 329
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 320
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 299
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 268
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 257
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 236
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 207
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 187
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 180
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 172
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 165
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 159
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 151
Septic sacroiliitis: an uncommon septic arthritis 149
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 140
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 136
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 135
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 135
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 135
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 133
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 131
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 130
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 126
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 125
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 123
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 123
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 122
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 122
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 121
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 119
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 116
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 116
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 116
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 113
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 113
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 109
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 109
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 108
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 106
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 105
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 104
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 104
Preliminary classification criteria for the cryoglobulinaemic vasculitis 103
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 102
New therapeutic effects of cilostazol in patients with ischemic disorders. 101
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 99
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 97
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 96
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 95
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 95
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 94
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 90
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 89
Artrite reumatoide. Terapia 88
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 84
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 84
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 84
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 83
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 83
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 83
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 83
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 83
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 82
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 82
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 82
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 81
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 81
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 80
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 80
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 79
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 78
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 78
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 76
Polimialgia reumatica ed arterite temporale di Horton 76
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 76
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 76
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 75
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 75
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 72
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 72
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 71
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 71
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 71
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 70
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 70
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 69
Validation of the classification criteria for cryoglobulinaemic vasculitis 68
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 68
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. 67
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 66
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 66
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 66
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 65
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 64
New therapeutic effects of cilostazol in patients with ischemic disorders 64
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 64
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 63
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 63
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 63
Totale 11.318
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.133 0 0 182 254 242 380 239 131 123 144 253 185
2020/20211.919 129 189 261 165 230 89 167 38 239 106 255 51
2021/20221.961 219 158 60 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/2025457 73 93 291 0 0 0 0 0 0 0 0 0
Totale 16.321